Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells

  • Xu, Dao-Jing (Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University) ;
  • Zhao, Ying-Ze (Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University) ;
  • Wang, Jin (Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University) ;
  • He, Juan-Wen (Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University) ;
  • Weng, Ya-Guang (Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University) ;
  • Luo, Jin-Yong (Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University)
  • Received : 2011.10.21
  • Accepted : 2011.11.07
  • Published : 2012.04.30


Although previous studies have demonstrated that BMP9 is highly capable of inducing osteogenic differentiation of mesenchymal stem cells, the molecular mechanism involved remains to be fully elucidated. In this study, we showed that BMP9 simultaneously promotes the activation of Smad1/5/8, p38 and ERK1/2 in C3H10T1/2 cells. Knockdown of Smad4 with RNA interference reduced nuclear translocation of Smad1/5/8, and disrupted BMP9-induced osteogenic differentiation. BMP9-induced osteogenic differentiation was blocked by p38 inhibitor SB203580, whereas enhanced by ERK1/2 inhibitor PD98059. SB203580 decreased BMP9-activated Smads singling, and yet PD98059 stimulated Smads singling in C3H10T1/2 cells. The effects of inhibitor were reproduced with adenovirus expressing siRNA targeted p38 and ERK1/2, respectively. Taken together, our findings revealed that Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation. Also, it is noteworthy that p38 and ERK1/2 may play opposing regulatory roles in mediating BMP9-induced osteogenic differentiation of C3H10T1/2 cells.


Bone morphogenetic proteins;Mesenchymal stem cells;Mitogen activated protein kinases;Osteogenic differentiation;Smads


Supported by : National Natural Science Foundation of China, Natural Science Foundation


  1. Deng, Z. L., Sharff, K. A., Tang, N., Song, W. X., Luo, J., Luo, X., Chen, J., Bennett, E., Reid, R., Manning, D., Xue, A., Montag, A. G., Luu, H. H., Haydon, R. C. and He, T. C. (2008) Regulation of osteogenic differentiation during skeletal development. Frontiers Biosci. 13, 2001-2021.
  2. Hogan, B. L. (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594.
  3. Chen, D., Zhao, M. and Mundy, G. R. (2004) Bone morphogenetic proteins. Growth Factors 22, 233-241.
  4. Boraiah, S., Paul, O., Hawkes, D., Wickham, M. and Lorich, D. G. (2009) Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin. Orthop. Relat. Res. 467, 3257-3262.
  5. Rutherford, R. B., Nussenbaum, B. and Krebsbach, P. H. (2003) Bone morphogenetic protein 7 ex vivo gene therapy. Drug News Perspect 16, 5-10.
  6. Kang, Q., Sun, M. H., Cheng, H., Peng, Y., Montag, A. G., Deyrup, A. T., Jiang, W., Luu, H. H., Luo, J., Szatkowski, J. P., Vanichakarn, P., Park, J. Y., Li, Y., Haydon, R. C. and He, T. C. (2004) Characterization of the distinct orthotopic boneforming activity of 14 BMPs using recombinant adenovirusmediated gene delivery. Gene Ther. 11, 1312-1320.
  7. Luu, H. H., Song, W. X., Luo, X., Manning, D., Luo, J., Deng, Z. L., Sharff, K. A., Montag, A. G., Haydon, R. C. and He, T. C. (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J. Orthop. Res. 25, 665-677.
  8. Luo, J., Tang, M., Huang, J., He, B. C., Gao, J. L., Chen, L., Zuo, G. W., Zhang, W., Luo, Q., Shi, Q., Zhang, B. Q., Bi, Y., Luo, X., Jiang, W., Su, Y., Shen, J., Kim, S. H., Huang, E., Gao, Y., Zhou, J. Z., Yang, K., Luu, H. H., Pan, X., Haydon, R. C., Deng, Z. L. and He, T. C. (2010) TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J. Biol. Chem. 285, 29588-29598.
  9. Wu, N., Zhao, Y., Yin, Y., Zhang, Y. and Luo, J. (2010) Identification and analysis of type II TGF-{beta} receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. Acta Biochim. Biophys. Sin. (Shanghai) 42, 699-708.
  10. Heldin, C. H., Miyazono, K. and ten Dijke, P. (1997) TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
  11. Chang, S. F., Chang, T. K., Peng, H. H., Yeh, Y. T., Lee, D. Y., Yeh, C. R., Zhou, J., Cheng, C. K., Chang, C. A. and Chiu, J. J. (2009) BMP-4 induction of arrest and differentiation of osteoblast- like cells via p21 CIP1 and p27 KIP1 regulation. Mol. Endocrinol. 23, 1827-1838.
  12. Gallea, S., Lallemand, F., Atfi, A., Rawadi, G., Ramez, V., Spinella-Jaegle, S., Kawai, S., Faucheu, C., Huet, L., Baron, R. and Roman-Roman, S. (2001) Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28, 491-498.
  13. Noth, U., Tuli, R., Seghatoleslami, R., Howard, M., Shah, A., Hall, D. J., Hickok, N. J. and Tuan, R. S. (2003) Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp. Cell Res. 291, 201-211.
  14. Celil, A. B. and Campbell, P. G. (2005) BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J. Biol. Chem. 280, 31353-31359.
  15. Cargnello, M. and Roux, P. P. (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75, 50-83.
  16. Verheyen, E. M. (2007) Opposing Effects of Wnt and MAPK on BMP/Smad Signal Duration. Dev. Cell 13, 755-756.
  17. Miyazono, K., Kamiya, Y., and Morikawa, M. (2010) Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147, 35-51.
  18. Song, J. J., Celeste, A. J., Kong, F. M., Jirtle, R. L., Rosen, V. and Thies, R. S. (1995) Bone morphogeneticprotein-9 binds to liver cells and stimulates proliferation. Endocrinology 136, 4293-4297.
  19. Lopez-Coviella, I., Berse, B., Krauss, R., Thies, R. S. and Blusztajn, J. K. (2000) Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP9. Science 289, 313-316.
  20. Chen, C., Grzegorzewski, K. J., Baras, S., Zhao, Q., Schneider, H., Wang, Q., Singh, M., Pukac, L., Bell, A. C., Duan, R., Coleman, T., Duttaroy, A., Cheng, S., Hirsch, J., Zhang, L., Lazard, Y., Fischer, C., Barber, M. C., Ma, Z. D., Zhang, Y. Q., Reavey, P., Zhong, L., Teng, B., Sanyal, I., Ruben, S. M., Blondel, O. and Birse, C. E. (2003) An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat. Biotechnol. 21, 294-301.
  21. Truksa, J., Peng, H., Lee, P. and Beutler, E. (2006) Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferring receptor 2 (Tfr2), and IL-6. Proc. Natl. Acad. Sci. U.S.A. 103, 10289-10291.
  22. Cao, X. and Chen, D. (2005) The BMP signaling and in vivo bone formation. Gene 357, 1-8.
  23. Heffron, D. S. and Mandell, J. W. (2005) Opposing roles of ERK and p38 MAP kinases in FGF2-induced astroglial process extension. Mol. Cell Neurosci. 28, 779-790.
  24. Shields, J. M., Mehta, H., Pruitt, K. and Der, C. J. (2002) Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol. Cell Biol. 22, 2304-2317.
  25. Payne, K. A., Meszaros, L .B., Phillippi, J. A. and Huard, J. (2010) Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle- derived stem cells. Tissue Eng. Part A 16, 3647-3655.

Cited by

  1. A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9 vol.19, pp.2, 2017,
  2. BMP signaling in mesenchymal stem cell differentiation and bone formation vol.06, pp.08, 2013,
  3. Dickkopf-1 is involved in BMP9-induced osteoblast differentiation of C3H10T1/2 mesenchymal stem cells vol.49, pp.3, 2016,
  4. Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine vol.2013, 2013,
  5. Emodin promotes the osteogenesis of MC3T3-E1 cells via BMP-9/Smad pathway and exerts a preventive effect in ovariectomized rats 2017,
  6. Key transcription factors in the differentiation of mesenchymal stem cells vol.92, pp.1-2, 2016,
  7. Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro vol.28, pp.9, 2016,
  8. Platelet Rich Plasma (PRP) Produces an Atherofibrotic Histophenotype During Craniofacial Bone Repair Due to Changes of Immunohistochemical Expression of Erk1/2, p38α/β, Adiponectin and Elevated Presence of Cells Exhibiting B-scavenger Receptor (CD36+) vol.27, pp.3, 2016,
  9. Osteogenic potential of rhBMP9 combined with a bovine-derived natural bone mineral scaffold compared to rhBMP2 vol.28, pp.4, 2017,
  10. RUNX1 Plays an Important Role in Mediating BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Line C3H10T1/2, Murine Multi-Lineage Cells Lines C2C12 and MEFs vol.18, pp.7, 2017,
  11. Potential Roles of Bone Morphogenetic Protein (BMP)-9 in Human Liver Diseases vol.15, pp.4, 2014,
  12. TNFα and IL-1β influence the differentiation and migration of murine MSCs independently of the NF-κB pathway vol.5, pp.4, 2014,
  13. Analysis and characterization of the functional TGFβ receptors required for BMP6-induced osteogenic differentiation of mesenchymal progenitor cells vol.46, pp.2, 2013,
  14. Identification of a Growth Factor Mimicking the Synergistic Effect of Fetal Bovine Serum on BMP-9 Cell Response vol.20, pp.17-18, 2014,
  15. Proteomics approaches for the studies of bone metabolism vol.47, pp.3, 2014,
  16. Downregulated microRNA-23b promotes BMP9-mediated osteogenesis in C2C12 myoblast cells by targeting Runx2 vol.13, pp.3, 2016,
  17. Bone Morphogenetic Protein-9 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells via the JNK Pathway vol.12, pp.1, 2017,
  18. Crosstalk between Wnt/β-Catenin and Estrogen Receptor Signaling Synergistically Promotes Osteogenic Differentiation of Mesenchymal Progenitor Cells vol.8, pp.12, 2013,
  19. Potential Roles of BMP9 in Liver Fibrosis vol.15, pp.11, 2014,
  20. Cross-Talk Between VEGF and BMP-6 Pathways Accelerates Osteogenic Differentiation of Human Adipose-Derived Stem Cells vol.230, pp.11, 2015,
  21. Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2 vol.45, pp.8, 2013,
  22. Inhibition of actin polymerization decreases osteogeneic differentiation of mesenchymal stem cells through p38 MAPK pathway vol.20, pp.1, 2013,
  23. Endoplasmic Reticulum (ER) Stress Inducible Factor Cysteine-Rich with EGF-Like Domains 2 (Creld2) Is an Important Mediator of BMP9-Regulated Osteogenic Differentiation of Mesenchymal Stem Cells vol.8, pp.9, 2013,
  24. BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses vol.10, pp.4, 2015,
  25. Effect of BMP-2 and/or BMP-9 on preosteoblasts attached to polycaprolactone functionalized by adhesive peptides derived from bone sialoprotein vol.34, pp.4, 2013,
  26. Nanoparticulate Mineralized Collagen Scaffolds and BMP-9 Induce a Long-Term Bone Cartilage Construct in Human Mesenchymal Stem Cells vol.5, pp.14, 2016,
  27. BMP9-Induced Survival Effect in Liver Tumor Cells Requires p38MAPK Activation vol.16, pp.9, 2015,
  28. Sika Deer Antler Collagen Type I-Accelerated Osteogenesis in Bone Marrow Mesenchymal Stem Cells via the Smad Pathway vol.2016, 2016,
  29. Effects of BMP9 and pulsed electromagnetic fields on the proliferation and osteogenic differentiation of human periodontal ligament stem cells vol.38, pp.1, 2017,
  30. Co-stimulation with bone morphogenetic protein-9 and FK506 induces remarkable osteoblastic differentiation in rat dedifferentiated fat cells vol.440, pp.2, 2013,
  31. Sulforaphane (SFN) regulates dedifferentiation and cyclooxygenase-2 (COX-2) expression via MAPkinase pathway in rabbit articular chondrocytes vol.3, pp.1, 2013,
  32. All-trans retinoic acid restored the osteogenic ability of BMP9 in osteosarcoma through the p38 MAPK pathway vol.50, pp.4, 2017,
  33. Modulation of MAPK signalling by immobilized adhesive peptides: Effect on stem cell response to BMP-9-derived peptides vol.31, 2016,
  34. The healing of alveolar bone defects with novel bio-implants composed of Ad-BMP9-transfected rDFCs and CHA scaffolds vol.7, pp.1, 2017,
  35. Retraction: P38 and ERK1/2 MAPKs Act in Opposition to Regulate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells vol.13, pp.11, 2018,
  36. A bioactive collagen membrane that enhances bone regeneration pp.15524973, 2018,
  37. BMP9 stimulates joint regeneration at digit amputation wounds in mice vol.10, pp.1, 2019,